Briegel K, Hentsch B, Pfeuffer I, Serfling E
Institut für Virologie und Immunbiologie, Universität Würzburg, FRG.
Nucleic Acids Res. 1991 Nov 11;19(21):5929-36. doi: 10.1093/nar/19.21.5929.
The inducible, T cell-specific enhancers of murine and human Interleukin 2 (Il-2) genes contain the kB-like sequence GGGATTTCACC as an essential cis-acting enhancer motif. When cloned in multiple copies this so-called TCEd (distal T cell element) acts as an inducible proto-enhancer element in E14 T lymphoma cells, but not in HeLa cells. In extracts of induced, Il-2 secreting El4 cells three individual protein factors bind to TCEd DNA. The binding of the most prominent factor, named TCF-1 (T cell factor 1), is correlated with the proto-enhancer activity of TCEd. TCF-1 consists of two polypeptides of about 50 kD and 105 kD; the former seems to be related to the 50 kD polypeptide of NF-kB. Purified NF-kB is also able to bind to the TCEd, but TCF-1 binds stronger than NF-kB to TCEd DNA. The conversion of the TCEd to a 'perfect' NF-kB binding site leads to a tighter binding of NF-kB to TCEd DNA and, as a functional consequence, to the activity of the 'converted' TCEd motifs in HeLa cells. Thus, the substitution of the underlined A residue to a C within the GGGATTTCACC motif abolishes its T cell-restricted activity and leads to its functioning in both El4 cells and HeLa cells. These results indicate that lymphocyte-specific factors binding to the TCEd are involved in the control of T cell specific-transcription of the Il-2 gene.
小鼠和人类白细胞介素2(Il-2)基因的可诱导性、T细胞特异性增强子含有类似kB的序列GGGATTTCACC,作为一种必需的顺式作用增强子基序。当以多个拷贝进行克隆时,这个所谓的TCEd(远端T细胞元件)在E14 T淋巴瘤细胞中作为一种可诱导的原增强子元件发挥作用,但在HeLa细胞中则不然。在诱导分泌Il-2的E14细胞提取物中,三种单独的蛋白质因子与TCEd DNA结合。最主要的因子,即TCF-1(T细胞因子1)的结合与TCEd的原增强子活性相关。TCF-1由两条约50 kD和105 kD的多肽组成;前者似乎与NF-kB的50 kD多肽相关。纯化的NF-kB也能够与TCEd结合,但TCF-1比NF-kB与TCEd DNA的结合更强。将TCEd转化为一个“完美的”NF-kB结合位点会导致NF-kB与TCEd DNA的结合更紧密,并且作为一种功能结果,会导致“转化后的”TCEd基序在HeLa细胞中具有活性。因此,将GGGATTTCACC基序中带下划线的A残基替换为C会消除其T细胞限制性活性,并导致其在E14细胞和HeLa细胞中均发挥作用。这些结果表明,与TCEd结合的淋巴细胞特异性因子参与了Il-2基因的T细胞特异性转录调控。